SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
Open Access
- 8 April 2016
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 16 (1) , 1-9
Abstract
Endometrial cancer (EC) is the most common form of malignant gynecological tumor. Treatment with cisplatin (CDDP) is the mainstay of EC chemotherapy. The apoptotic machinery is regarded as an important etiological factor in chemoresistance. Recent evidence has suggested that overexpression of the transcription factor SOX17 prevented apoptosis in tumor cell lines. The effect of SOX17 on apoptosis in EC cisplatin chemoresistance remains unclear. Immunohistochemistry and the reverse transcription-polymerase chain reaction were employed to detect gene expression in paraffin-embedded EC tissues and blood samples. The anti-proliferative ability of SOX17 on EC cells was assessed by MTT. Flow cytometric analysis was used to detect cell apoptosis by annexin V/PI double-staining. The expression of apoptosis-related proteins was analyzed by western blot. In the in vivo study, nude mice were subcutaneously injected with EC cells, and received cisplatin treatment through intraperitoneal chemotherapy. Apoptosis of in vivo samples was analyzed by TUNEL assay. SOX17 expression decreased the chemical resistance of EC cells to CDDP. HEC-1B cells with an elevated expression of SOX17 had a lower cell viability and higher apoptosis rate after cisplatin exposure. Overexpression SOX17 up-regulated wild type p53 after being exposed to cisplatin, while the expression of BCL2-associated X protein and cleaved caspase-3 simultaneously increased. Caspase-9 inhibitor reduced the efficacy of SOX17 in HEC-1B cells after cisplatin treatment. In the in vivo study, SOX17 overexpression clearly restrained the tumor growth and increased the cisplatin toxicity and apoptosis of tumor cells. SOX17 is involved in the p53-mediated apoptosis pathway, and increases the sensitivity of HEC-1B cells to cisplatin.Keywords
Funding Information
- The National Natural Science Foundation of China (81272885, 81172476)
This publication has 33 references indexed in Scilit:
- Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinomaOncogene, 2012
- WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cellsOncogene, 2012
- The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activationOncogene, 2011
- Revised FIGO staging for carcinoma of the endometriumInternational Journal of Gynecology & Obstetrics, 2009
- UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasionFEBS Letters, 2008
- The association between p53 expression, stage and histological features in endometrial cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomasVirchows Archiv, 2005
- The Pathophysiology of Mitochondrial Cell DeathScience, 2004
- Ways of dying: multiple pathways to apoptosisGenes & Development, 2003
- A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genesNature, 1990